SCHEMBL4829968

SCHEMBL4829968

Cc1cc(C)c(S(=O)(=O)On2c(=O)c3cc4c(=O)n(OS(=O)(=O)c5c(C)cc(C)cc5C)c(=O)c4cc3c2=O)c(C)c1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 1/20 0.38
CA2 P00918 1/20 0.38
MMP1 P03956 1/20 0.38
MMP2 P08253 1/20 0.38
MMP9 P14780 1/20 0.38
MMP8 P22894 1/20 0.38
MMP13 P45452 1/20 0.38
RAPGEF4 Q8WZA2 7/20 0.38
GAA P10253 1/20 0.37
NPSR1 Q6W5P4 3/20 0.37
MAPT P10636 4/20 0.36
MEN1 O00255 3/20 0.36
KMT2A Q03164 3/20 0.36
LMNA P02545 2/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
KDM4E B2RXH2 2/20 0.36
CYP3A4 P08684 2/20 0.36
CYP1A2 P05177 1/20 0.36
HPGD P15428 1/20 0.36
XBP1 P17861 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4835154 0.76 VDR (0.53) CA1CA2MMP2GAANPSR1
SCHEMBL4829809 0.76 ALDH1A1 (0.57) GAAMAPTMEN1KMT2ALMNA
SCHEMBL7519092 0.74 MAPT (0.43) CA1CA2MMP1MMP2MMP9
SCHEMBL5556202 0.74 KDM4E (0.50) CA1CA2MMP1MMP2MMP9
SCHEMBL4835204 0.72 MAPT (0.42) CA1CA2MMP1MMP2MMP9
SCHEMBL65774 0.72 PARL (0.50) CA1CA2MMP1MMP2MMP9
SCHEMBL4831954 0.72 ALDH1A1 (0.40) MAPTMEN1KMT2ALMNAKDM4E
SCHEMBL3827616 0.71 ALDH1A1 (0.36) CA1CA2GAANPSR1ALDH1A1
SCHEMBL2678329 0.71 CA1 (0.50) CA1CA2MMP1MMP2MMP9
SCHEMBL4835081 0.69 MAPT (0.39) CA1CA2MMP1MMP2MMP9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7374857-B2 Bismide compound, acid generator and resist composition each containing the same, and method of forming pattern from the composition WAKO PURE CHEMICAL INDUSTRIES LTD. (JP) 2008-05-20 US disclosed
US-20050038261-A1 Bismide compound, acid generator and resist composition each containing the same, and method of forming pattern from the composition WAKO PURE CHEMICAL INDUSTRIES LTD. (JP) 2005-02-17 US disclosed
EP-1449833-A1 BISIMIDE COMPOUND, ACID GENERATOR AND RESIST COMPOSITION EACH CONTAINING THE SAME, AND METHOD OF FORMING PATTERN FROM THE COMPOSITION Wako Pure Chemical Industries, Ltd. (JP) 2004-08-25 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050038261-A1 Bismide compound, acid generator and resist composition each containing the same, and method of forming pattern from the composition ASIC1, GAR1, RER1 CA1 603/4885CA2 1249/4885MMP1 4672/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.